Cite

HARVARD Citation

    Lowery, M. et al. (2018). Phase II trial of veliparib in patients with previously treated BRCA-mutated pancreas ductal adenocarcinoma. European journal of cancer. pp. 19-26. [Online]. 
  
Back to record